Insys Therapeutics, Inc. (INSY) stock prices updated...
 

Insys Therapeutics, Inc. stock price

Insys Therapeutics, Inc. latest news:


  • 02/08/2018 14:23:43

    Maryland sues Insys to enforce subpoena in opioid probe

    Maryland's attorney general has filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc (INSY) as part of an investigation into allegations the drugmaker deceptively marketed a fentanyl-based cancer pain medicine.

  • 02/01/2018 21:23:04

    UPDATE 2-New York accuses Insys of deceptively marketing opioid

    Feb 1 (Reuters) - Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses.

  • 02/01/2018 21:06:34

    BRIEF-Insys Therapeutics Addresses New York AG's Complaint

    Insys Therapeutics Inc(INSY): * INSYS THERAPEUTICS ADDRESSES NEW YORK ATTORNEY GENERAL'S COMPLAINT. * INSYS THERAPEUTICS(INSY) - ‍INTEND TO CONTINUE WORKING COLLABORATIVELY WITH ALL RELEVANT AUTHORITIES TO RESOLVE OUTSTANDING GOVERNMENTAL INVESTIGATIONS​ Source text for Eikon: Further company coverage:

  • 02/01/2018 13:32:35

    UPDATE 1-New York accuses Insys of deceptively marketing opioid

    Feb 1 (Reuters) - Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses.

  • 02/01/2018 12:49:52

    New York accuses Insys of deceptively marketing opioid

    Feb 1 (Reuters) - New York's attorney general on Thursday filed a lawsuit against Insys Therapeutics Inc seeking $75 million from the pharmaceutical company, which he said deceptively promoted a powerful fentanyl-based cancer pain medicine for unsafe uses.

  • 01/11/2018 14:14:22

    Ex-Insys employee seeks ban on mentioning 'opioid crisis' at trial

    Jan 11 (Reuters) - A former Insys Therapeutics Inc employee accused of engaging in a scheme to pay medical practitioners kickbacks to prescribe a fentanyl-based treatment is seeking to bar U.S. prosecutors from referring to the "opioid crisis" at his trial.

  • 12/21/2017 11:07:12

    REFILE-UPDATE 1-North Carolina accuses drugmaker Insys of scheme to push opioid

    BOSTON, Dec 21 (Reuters) - North Carolina sued Insys Therapeutics Inc on Thursday, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys to boost profits amid the U.S. opioid epidemic.

  • 12/20/2017 13:20:24

    New Mexico adds Insys, Mallinckrodt to opioid epidemic lawsuit

    New Mexico on Wednesday added claims against drugmakers Insys Therapeutics Inc (INSY) and Mallinckrodt Plc (MNK) in a lawsuit accusing various opioid manufacturers and distributors of helping fuel a drug addiction epidemic in the state.

  • 11/27/2017 17:12:57

    Billionaire Insys founder can remove ankle monitor -judge

    BOSTON, Nov 27 (Reuters) - The billionaire founder of Insys Therapeutics Inc, charged with engaging in a scheme to bribe doctors to prescribe an opioid, won the lifting of a requirement that he wear a GPS-enabled ankle monitor on Monday, which he said interfered with jogging.

  • More trends:

    Intec Pharma Ltd.NTEC | Integra LifeSciences Holdings CorporationIART | Integrated Device Technology, Inc.IDTI | Integrated Electrical Services, Inc.IESC | Integrated Silicon Solution, Inc.ISSI | Intel CorporationINTC | Inteliquent, Inc.IQNT | Intellipharmaceutics International Inc.IPCI | Inter Parfums, Inc.IPAR | Interactive Brokers Group, Inc.IBKR |